- $14.17m
- $68.47m
- 32
- 52
- 23
- 27
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.17 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 5.61 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -8.69% | ||
| Return on Equity | -31.41% | ||
| Operating Margin | -558.3% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | 3.42 | 3.11 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
OSR Holdings, Inc. is a global healthcare holding company dedicated to advancing biomedical innovation approaches to health and wellness. Through its subsidiaries, it is engaged in immuno-oncology, regenerative biologics, and medical device technologies. Its operating businesses include developing oral immunotherapies for the treatment of cancer, developing design-augmented (DA) biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. Its subsidiaries include VAXIMM AG (Vaximm); RMC Co., Ltd. (RMC); Darnatein Co., Ltd. (Darnatein), and Woori IO Co., Ltd. (Woori IO). Vaximm is developing oral immunotherapies for the treatment of cancer and immunological disorders. RMC is a Korea-based neurovascular intervention medical device and systems distribution company. Darnatein is developing DA biologics for age-related and other degenerative diseases. Woori IO is a South Korea-based medical device company.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- September 30th, 2025
- Incorporated
- February 25th, 2020
- Public Since
- February 10th, 2023
- No. of Shareholders
- 9
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market- Shares in Issue
- 25,757,126
- Address
- 10900 Ne 4Th Street, Suite 2300, BELLEVUE, 98004
- Web
- https://osr-holdings.com/
- Phone
- +1 4256357700
- Auditors
- WithumSmith Brown PC
Upcoming Events for OSRH
Q1 2026 OSR Holdings Inc Earnings Release
Similar to OSRH
ABPRO Holdings
NASDAQ Capital Market
ABVC Biopharma
NASDAQ Capital Market
Acesis Holdings
NASDAQ Capital Market
Achieve Life Sciences
NASDAQ Capital Market
Aclarion
NASDAQ Capital Market
FAQ
What is the OSR Holdings share price?
As of Today at 21:31 UTC, shares in OSR Holdings are trading at $0.55. This share price information is delayed by 15 minutes.
How has the OSR Holdings share price performed this year?
Shares in OSR Holdings last closed at $0.55 and the price had moved by -95.19% over the past 365 days. In terms of relative price strength the OSR Holdings share price has underperformed the S&P500 Index by -95.82% over the past year.
What are the analyst and broker recommendations for OSR Holdings?
The overall consensus recommendation for OSR Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the OSR Holdings dividend yield?
OSR Holdings does not currently pay a dividend.
Does OSR Holdings pay a dividend?
OSR Holdings does not currently pay a dividend.
When does OSR Holdings next pay dividends?
OSR Holdings does not currently pay a dividend.
How do I buy OSR Holdings shares?
To buy shares in OSR Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of OSR Holdings?
As of the previous close price of $0.55, shares in OSR Holdings had a market capitalisation of $14.17m.
Where are OSR Holdings shares listed?
Here are the trading details for OSR Holdings:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: OSRH
What kind of share is OSR Holdings?
Based on an overall assessment of its quality, value and momentum OSR Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a OSR Holdings share price forecast for 2026?
The analyst consensus target price for shares in OSR Holdings is $10.00. That is 1718.18% above the last closing price of $0.55.
Analysts covering OSR Holdings currently have a consensus Earnings Per Share (EPS) forecast of -$0.97 for the next financial year.
Find out moreWhat is the trend in the OSR Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like OSR Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -16.27%.
As of the last closing price of $0.55, shares in OSR Holdings were trading -35.29% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the OSR Holdings PE Ratio?
The OSR Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.55.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of OSR Holdings?
We do not have data on OSR Holdings' directors